Computer-aided detection (CAD) software developer CureMetrix has appointed Tracy John Robertson as its new executive vice president of business development.
A 30-year healthcare industry veteran, Robertson comes to CureMetrix from VasoHealthcare, where he led the women's health group. He has a background in radiologic technology and MRI clinical research, and he led GE Healthcare's advanced MRI applications group before launching a MRI consultancy, according to CureMetrix. He also spent 16 years at Siemens Healthineers in management roles.
Robertson will be responsible for continuing CureMetrix's expansion into new markets, identifying new business ventures, and developing a global network of clinical and strategic partnerships, the company said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
